Best Target therapy for lung cancer Doctors Abroad for Australian Patients

Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in Texas – consistently ranked as one of the world's top hospitals for oncology.

• Specialises in immunotherapy protocols using Keytruda for advanced lung malignancies
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Expert in coordinating systemic treatments for complex solid tumours and sarcomas
• Focuses on precision medicine through targeted therapy and molecular interventions
• Former clinical oncologist at major Turkish training and research hospitals

Professor Tanrikulu is a leading medical oncologist at Anadolu Medical Center who ranked third nationwide in the Turkish specialty examinations. She completed a specialist lung cancer preceptorship at The Christie in Manchester to refine her expertise in thoracic malignancies.

• Specialises in matching targeted therapies to the unique genetic profile of lung tumours
• Serves as the lead researcher for multiple international clinical trials on cancer therapies
• Former Head of the Medical Oncology Unit at Haydarpaşa Numune Training Hospital
• Member of the European Society for Medical Oncology (ESMO) and ASCO
• Completed advanced colorectal cancer training at Oxford University in England

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital, known for his focus on thoracic and gastrointestinal malignancies.

• Promoted to Associate Professor in 2016 following extensive clinical research
• Held senior clinical roles at the Ankara Oncology Clinic in Turkey
• Served as a specialist at the Erzurum Regional Training and Research Hospital
• Focuses on precision medicine for lung cancer and complex gastrointestinal cases
• Medical graduate of Selcuk University Faculty of Medicine

Professor Cemil Bilir is a distinguished medical oncologist who completed a prestigious fellowship at the Center for Pharmaceutical Biotechnology and Nanomedicine in Boston.

• Holds a Professor title at Sakarya University Faculty of Medicine
• Broadened clinical expertise through training at the world-renowned Cleveland Clinic
• Active member of the American Society of Clinical Oncology (ASCO)
• Currently pursuing a PhD in Inorganic Chemistry to better understand drug interactions
• Maintains professional standing with the European Society for Medical Oncology (ESMO)

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital, specialising in targeted therapies for complex lung cancer cases.

• Coordinates medical oncology education, ensuring he remains at the forefront of emerging cancer protocols
• Published research on survival outcomes specifically for locally advanced and metastatic non-small cell lung cancer
• Member of the American Society of Clinical Oncology (ASCO)
• Focuses on personalized treatment plans based on specific genetic markers and patient BMI profiles

Ercan Ozden is a specialist in medical oncology at VM Medical Park Pendik Hospital, having completed his subspecialty training at Kocaeli University.

• Trained at Istanbul University Cerrahpaşa Faculty of Medicine
• Background in internal medicine provides a strong foundation for managing complex cases
• Focuses on systemic treatments including targeted therapies and immunotherapy
• Collaborates with multidisciplinary teams to tailor cancer treatment plans

Professor Alemdar is a dual-certified specialist in internal medicine and medical oncology with extensive expertise in treating advanced respiratory malignancies.

• Trained at Akdeniz University Faculty of Medicine – a leading Turkish research institution
• Specialises in precise systemic treatments for complex lung cancer cases
• Served at major clinical hubs including Antalya Training and Research Hospital
• Expertise in identifying specific genetic markers for targeted drug therapies
• Member of the Turkish Medical Oncology Society

Associate Professor Nail Paksoy is a highly specialized medical oncologist who has served as a sub-investigator on major international clinical trials for lung and breast cancer treatments.

• Holds ESMO Board Certification in Medical Oncology, recognized as the gold standard for oncologists in Europe
• Specialises in targeted therapies for ALK-positive and ROS1 fusion-positive lung cancers
• Conducted extensive research on the efficacy of inhibitors like Crizotinib and Lorlatinib
• Member of Turkey's leading oncology institutes with a focus on personalized medicine

Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads research as a primary investigator on more than 200 clinical trials.

• Trained in surgical oncology at the Tata Memorial Hospital in Mumbai
• Holds a membership with the Royal College of Surgeons in Edinburgh
• Specialises in thoracic oncology with a focus on lung and chest tumours
• Professor for surgical oncology for the Delhi National Board
• Active in phase 1 to 3 clinical trials for new cancer therapies

Dr Shaunak Valame focuses on the molecular basis of cancer to deliver precise targeted therapies at HCG Manavata Cancer Centre.

• Trained in Medical Oncology at Indraprastha Apollo Hospital in New Delhi
• Presented research to the American Society of Clinical Oncology in San Francisco
• Completed a registrarship at the Jawaharlal Nehru Cancer Hospital and Research Centre
• Specialises in matching specific genetic mutations to modern drug treatments
• Experienced in delivering lectures for international oncology programmes